Dekker Nicky, van 't Veer Mars B, Aleman Berthe M P, van Leeuwen Flora E, Raemaekers John M M
*Namens het BETER-consortium, waarvan de deelnemers aan het eind van dit artikel vermeld staan.
Ned Tijdschr Geneeskd. 2015;159:A9269.
The Dutch BETER consortium has established a national care infrastructure for Hodgkin lymphoma survivors. 'BETER' [the Dutch word for 'better'] stands for Better care after Hodgkin lymphoma (HL): Evaluation of long-term Treatment Effects and screening Recommendations. The survivorship care focuses on long-term effects of HL treatment. Over 10,000 HL survivors who were treated in the period spanning 1965-2008 have been identified. As part of the survivorship care initiative, specific BETER out-patient clinics have been set up. A dedicated website, www.beternahodgkin.nl, provides HL survivors with relevant information. The stakeholders of the BETER survivorship care programme aim to achieve an improved healthy life expectancy for patients treated for HL.
荷兰BETER联盟已为霍奇金淋巴瘤幸存者建立了全国性护理基础设施。“BETER”(荷兰语中意为“更好”)代表霍奇金淋巴瘤(HL)后的更好护理:长期治疗效果评估和筛查建议。幸存者护理聚焦于HL治疗的长期影响。现已确定了1965年至2008年期间接受治疗的1万多名HL幸存者。作为幸存者护理倡议的一部分,已设立了专门的BETER门诊。一个专门网站www.beternahodgkin.nl为HL幸存者提供相关信息。BETER幸存者护理计划的利益相关者旨在提高接受HL治疗患者的健康预期寿命。